Planteome: Term Details for "lovastatin biosynthetic process" (GO:0140735)

You are using the Cyverse mirror of the Planteome Ontology Browser. The main site is currently down for maintenance.

Notice

Some functionality on this page depends on JavaScript. To fully use the features of AmiGO 2, enable JavaScript in your browser and reload from the landing page.

Term Information

Accession: GO:0140735
Name: lovastatin biosynthetic process
Ontology: biological_process
Synonyms: lovastatin anabolism, lovastatin biosynthesis, lovastatin formation, lovastatin synthesis, mevacor anabolism, mevacor biosynthesis, mevacor biosynthetic process, mevacor formation, mevacor synthesis, mevinolin anabolism, mevinolin biosynthesis, mevinolin biosynthetic process, mevinolin formation,, mevinolin synthesis, monacolin K anabolism, monacolin K biosynthesis, monacolin K biosynthetic process, monacolin K formation, monacolin K synthesis
Alternate IDs: None
Definition: The chemical reactions and pathways resulting in the formation of lovastatin (also known as mevinolin, mevacor or monacolin K), a hypolipidemic inhibitor of (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR). Source: PMID:10334994, PMID:10381407
Comment: None
History: See term history for GO:0140735 at QuickGO
Subset: None
Related: Link to all annotated objects annotated to lovastatin biosynthetic process.; Link to all direct and indirect annotations to lovastatin biosynthetic process.; Link to all direct and indirect annotations download (limited to first 10,000) for lovastatin biosynthetic process.
Feedback: Contact the Planteome feedback if you find mistakes or have concerns about the data you find here.
Comments, changes to terms, or requests for new ontology terms can be made at GO issue tracker on GitHub.

Filter results

Viewing options

BFO:0000001 entity
BFO:0000003 occurrent
BFO:0000015 process
GO:0008150 biological_process
GO:0009987 cellular process
GO:0008152 metabolic process
GO:0009058 biosynthetic process
GO:0044237 cellular metabolic process
GO:0071704 organic substance metabolic process
GO:0044238 primary metabolic process
GO:0019748 secondary metabolic process
GO:0044249 cellular biosynthetic process
GO:0046483 heterocycle metabolic process
GO:0006629 lipid metabolic process
GO:1901360 organic cyclic compound metabolic process
GO:1901576 organic substance biosynthetic process
GO:0044550 secondary metabolite biosynthetic process
GO:0009404 toxin metabolic process
GO:1901568 fatty acid derivative metabolic process
GO:0018130 heterocycle biosynthetic process
GO:1901334 lactone metabolic process
GO:0008610 lipid biosynthetic process
GO:0043385 mycotoxin metabolic process
GO:1901362 organic cyclic compound biosynthetic process
GO:0030638 polyketide metabolic process
GO:0009403 toxin biosynthetic process
GO:1901570 fatty acid derivative biosynthetic process
GO:1901336 lactone biosynthetic process
GO:0043386 mycotoxin biosynthetic process
GO:0030639 polyketide biosynthetic process
GO:0140735 lovastatin biosynthetic process
GO:0140736 positive regulation of lovastatin biosynthetic process

Parents of lovastatin biosynthetic process (GO:0140735)

subject	relation	object
lovastatin biosynthetic process	is_a	polyketide biosynthetic process (GO:0030639)
lovastatin biosynthetic process	is_a	fatty acid derivative biosynthetic process (GO:1901570)
lovastatin biosynthetic process	is_a	mycotoxin biosynthetic process (GO:0043386)
lovastatin biosynthetic process	is_a	lactone biosynthetic process (GO:1901336)

Children of lovastatin biosynthetic process (GO:0140735)

subject	relation	object
positive regulation of lovastatin biosynthetic process (GO:0140736)	RO:0002213	lovastatin biosynthetic process

kegg.module: M00893
MetaCyc: PWY-7535